marijuana stocks news

Cara Therapeutics Inc. (CARA)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 914   1,125   960   178  
Cost of Revenue
Gross Profit 914   1,125   960   178  
Operating Expenses
Research Development 3,459 6,208 3,200 2,201
Selling General and Administrative 1,791 1,520 1,472 1,398
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (4,336) (6,603) (3,712) (3,421)
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes (4,314) (6,577) (3,656) (3,399)
Interest Expense
Income Before Tax (4,314) (6,577) (3,656) (3,399)
Income Tax Expense (142) (32) (11) (16)
Minority Interest
Net Income From Continuing Ops (4,172) (6,545) (3,645) (3,383)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (4,172) (6,545) (3,645) (3,383)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (4,172) (6,545) (3,645) (3,383)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Thumb Industries Inc. (GTBIF) to Open Rise Bloomfield in New Jersey

Green Thumb Industries to Open Rise Bloomfield in New Jersey, Its 65th…

United Cannabis Corporation (CNAB) Establishes Joint Venture for Industrial Hemp Processing Facility in South Carolina

United Cannabis Corporation Establishes Joint Venture for Industrial Hemp Processing Facility in…

Canopy Growth Corporation (CGC) to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August…